About Us

About Us

Our Mission

At Mimerigen we are revolutionizing the future of Precision Medicine and RNA Therapeutics with our Biomimetic RNA Platform. Our goal is to deliver a foundational molecular toolkit to help companies significantly advance their development and treatment of protein-linked diseases. We aim to solve the critical issues of scalability, cost, and stability in RNA production, enabling more effective and accessible treatments for everyone in need.

Our Story

This story isn’t about us, it’s about you: a mother who wants to grow old and watch her children and grandchildren grow up healthy, a father who dreams of walking his daughter down the aisle, or a friend who hopes for many more moments of laughter and joy. You fuel our passion and drive us to push the boundaries of what’s possible.
At the heart of our journey is a simple yet profound belief: no life should be lost to diseases we can fight. Imagine a world where ALS isn’t a death sentence, Alzheimer’s can be reversed, and cancer eradicated without chemotherapy. Our mission is to accelerate toward that world.
At Mimerigen, we are developing a breakthrough technology that has the potential to be a step change in the field of precision medicine. This technology offers new and existing companies the opportunity to rapidly design and develop cures for protein-linked and genetic disorders—cures tailored to fit you, your loved ones, and their loved ones.

Our Team

Will Hansen, PhD
Will Hansen, PhD
CEO & Founder,

Former Director of Chemistry, Detect
Rosetta developer & enzyme engineer

Devin Noonan
Devin Noonan
CBO & Co–Founder,

Former CRO, Bedrock
Kellogg Executive MBA

Kevin Harvey, PhD
Kevin Harvey, PhD
Board Director,

President, Aviva Systems Biology

Per Langö
Per Langö
Board Director,

CEO, GT Medical Technologies
Former CEO, Palette Life Sciences

We are creating a sustainable platform with targeted applications

Application

Modules

Platform

Scroll to Top